Darmowa i dyskretna wysyłka od 200 € - jakość potwierdzona laboratoryjnie

LabGain
ZPHC

Exemestane ZPHC — 25 mg × 100 tablets

0 opinii klientów
Cena na zapytanie

Exemestane (Aromasin®) — irreversible steroidal AI 100 film-coated tablets × 25 mg Mechanism: permanently deactivates aromatase, lowering estrogen by ≈ 85 % and boosting endogenous testosterone. Research uses: post-cycle therapy, estrogen-dependent breast cancer models, mitigation of gynecomastia & water retention. Dose guide (research): 12.5 mg EOD for mild E2 control · 25 mg EOD during high-aromatase cycles · 25 mg daily × 2 weeks in PCT protocols. Lipid support: monitor HDL/LDL; consider omeg

Niedostępny
1
  • Nr katalogowy: exemestane-zphc-25-mg-100-tablets-default
  • Marka: ZPHC
  • Kategoria: Post Cycle Therapy (PCT), Sterydy doustne

Exemestane (ZPHC) is an irreversible steroidal aromatase inhibitor supplied as 100 tablets of 25mg each. It permanently deactivates the aromatase enzyme, lowering circulating estrogen by roughly 85% while helping to boost endogenous testosterone.

Widely used during and after anabolic steroid cycles, Exemestane helps control estrogen-related side effects such as water retention and gynecomastia, making it a common on-cycle and PCT-support aromatase inhibitor.

Key Benefits

  • Irreversibly suppresses aromatase, providing durable estrogen control
  • Helps prevent and mitigate gynecomastia and water retention
  • Supports a rise in endogenous testosterone by lowering estrogenic feedback
  • Useful both during high-aromatizing cycles and in post-cycle protocols

Opinie (0)

Brak opinii.

Napisz opinię

Twoja ocena

Podobne produkty